Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for emotional nostril movements after rhinoplasty
IRCT20230418057953N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of botulinum toxin type A in rhinoplasty (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Emotional movements of nostrils. Started May 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhinoplasty
Beyond the preview
Go deeper on IRCT20230418057953N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230418057953N1.